Decreased Damage From Transient Focal Cerebral Ischemia by Transfusion of Zero-Link Hemoglobin Polymers in Mouse

被引:23
作者
Mito, Toshiaki [1 ]
Nemoto, Masaaki [1 ]
Kwansa, Herman [1 ]
Sampei, Kenji [1 ]
Habeeb, Murtuza [1 ]
Murphy, Stephanie J. [2 ]
Bucci, Enrico [3 ]
Koehler, Raymond C. [1 ]
机构
[1] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA
[2] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA
[3] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
blood substitutes; cerebral blood flow; hemoglobin-based oxygen carrier; middle cerebral artery occlusion; stroke; CELL-FREE HEMOGLOBIN; OXYGEN-TRANSPORT; HYPERVOLEMIC-HEMODILUTION; VASCULAR-RESPONSE; BLOOD-FLOW; CARRIER; PRESSURE; ENDOTHELIN-1; HEMATOCRIT; MODEL;
D O I
10.1161/STROKEAHA.108.526731
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Transfusion of large polymers of hemoglobin avoids the peripheral extravasation and hypertension associated with crosslinked tetrameric hemoglobin transfusion and may be more effective in rescuing brain from focal ischemia. Effects of transfusion of high-oxygen-affinity hemoglobin polymers of different weight ranges were determined. Methods-Hypervolemic exchange transfusion was performed during 2 hours of middle cerebral artery occlusion in mice. Results-Compared to transfusion with a 5% albumin solution or no transfusion, infarct volume was reduced 40% by transfusion of a 6% solution containing hemoglobin polymers in the nominal range 500 to 14 000 kDa. Infarct volume was not significantly reduced by transfusion of a lower concentration of 2% to 3% of this size range of polymers, 6% hemoglobin solutions without removal of polymers < 500 kDa or > 14000 kDa, or crosslinked hemoglobin tetramers with normal oxygen affinity. Exchange transfusion with the 6% solution of the 500 to 14 000 kDa hemoglobin polymers did not improve the distribution of cerebral blood flow during focal ischemia and, in mice without ischemia, did not affect flow to brain or other major organs. Conclusion-An intermediate size range of polymerized bovine hemoglobin possessing high oxygen affinity appears optimal for rescuing mouse brain from transient focal cerebral ischemia. A minimum concentration of a 6% solution is required, the rescue is superior to that obtained with crosslinked tetrameric hemoglobin possessing normal oxygen affinity, and tissue salvage is not associated with increased blood flow. This polymer solution avoids the adverse effects of severe renal and splanchnic vasoconstriction seen with crosslinked tetrameric hemoglobin. (Stroke. 2009; 40: 278-284.)
引用
收藏
页码:278 / 284
页数:7
相关论文
共 30 条
[1]  
ASPLUND K, 1988, STROKE, V19, P464
[2]  
Björkholm M, 2005, HAEMATOLOGICA, V90, P505
[3]   A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2 transporter [J].
Bobofchak, KM ;
Mito, T ;
Texel, SJ ;
Bellelli, A ;
Nemoto, M ;
Traystman, RJ ;
Koehler, RC ;
Brinigar, WS ;
Fronticelli, C .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (02) :H549-H561
[4]   Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid [J].
Bucci, E ;
Razynska, A ;
Kwansa, H ;
MathesonUrbaitis, B ;
OHearne, M ;
Ulatowski, JA ;
Koehler, RC .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 128 (02) :146-153
[5]   Effect of oncotic pressure of diaspirin cross-linked hemoglobin (DCLHb(TM)) on brain injury after temporary focal cerebral ischemia in rats [J].
Cole, DJ ;
Drummond, JC ;
Patel, PM ;
Nary, JC ;
Applegate, RL .
ANESTHESIA AND ANALGESIA, 1996, 83 (02) :342-347
[6]   Hypervolemic-hemodilution during cerebral ischemia in rats: Effect of diaspirin cross-linked hemoglobin (DCLHb) on neurologic outcome and infarct volume [J].
Cole, DJ ;
Drummond, JC ;
Patel, PM ;
Reynolds, LR .
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 1997, 9 (01) :44-50
[7]   Recommendations for standards regarding preclinical neuroprotective and restorative drug development [J].
Feinklestein, SP ;
Fisher, M ;
Furland, AJ ;
Goldstein, LB ;
Gorelick, PB ;
Kaste, M ;
Lees, KR ;
Traystman, RJ ;
Albers, GW ;
Anwer, UE ;
Ashwood, T ;
Barone, FC ;
Basta, SL ;
Bogousslavsky, J ;
Buchan, AM ;
Cady, WJ ;
Chan, PH ;
Clemens, JA ;
Cox, BF ;
Craddock, RE ;
Cramer, SC ;
del Zoppo, GJ ;
Dielrich, WD ;
Elliott, P ;
Faden, AI ;
Feuerstein, GZ ;
Ginsberg, MD ;
Gold, M ;
Greene, WL ;
Hall, ED ;
Hsu, CY ;
Hunter, AJ ;
Lai, M ;
Lesko, LM ;
Levy, DE ;
Li, FH ;
Locke, KW ;
Lodge, D ;
Lowe, D ;
Marcoux, FW ;
McCulloch, J ;
McDermott, J ;
Meibach, R ;
Messersmith, EK ;
Moseley, M ;
Moskowitz, MA ;
Mueller, AL ;
Munro, F ;
Nudo, RJ ;
Oeda, J .
STROKE, 1999, 30 (12) :2752-2758
[8]   CUSTOM-TAILORED HEMODILUTION WITH ALBUMIN AND CRYSTALLOIDS IN ACUTE ISCHEMIC STROKE [J].
GOSLINGA, H ;
EIJZENBACH, V ;
HEUVELMANS, JHA ;
DEVRIES, EV ;
MELIS, VMJ ;
SCHMIDSCHONBEIN, H ;
BEZEMER, PD .
STROKE, 1992, 23 (02) :181-188
[9]   Characterization of a new double-filament model of focal cerebral ischemia in heme oxygenase-2-deficient mice [J].
Goto, S ;
Sampei, K ;
Alkayed, NJ ;
Doré, S ;
Koehler, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 285 (01) :R222-R230
[10]   The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable [J].
Gould, SA ;
Moore, EE ;
Hoyt, DB ;
Ness, PM ;
Norris, EJ ;
Carson, JL ;
Hides, GA ;
Freeman, IHG ;
DeWoskin, R ;
Moss, GS .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 195 (04) :445-452